Intera 3000 HAI Pump Commercialization
Liver metastases from colorectal cancer; Intrahepatic cholangiocarcinoma (bile duct cancer within the liver)
Key Facts
About Intera Oncology
Intera Oncology is a private, commercial-stage medical device company advancing Hepatic Artery Infusion (HAI) therapy for liver-dominant metastatic cancers. The company's flagship product, the Intera 3000 HAI Pump, is an implantable device designed to deliver chemotherapy at significantly higher concentrations directly to liver tumors via the hepatic artery, aiming to improve efficacy and reduce systemic side effects. Founded by individuals personally impacted by these cancers, the company's mission is to expand access to HAI therapy, which is currently offered at a limited number of leading academic cancer centers. Intera Oncology operates in the oncology sector with a clear focus on a specific, high-need patient population.
View full company profile